| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $264,716,202 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R21CA300717 | Perfusion CT for liver radioembolization | 000 | 1 | NIH | 4/1/2026 | $409,141 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01ES038328 | Interplay between TET1-mediated epigenomic mechanisms and m6A RNA modification in pulmonary inflammation induced by particulate matter | 000 | 1 | NIH | 4/1/2026 | $749,640 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R00AG081453 | The contribution of air pollution to racial and ethnic disparities in Alzheimer’s disease and related dementias: An application of causal inference methods | 000 | 3 | NIH | 2/26/2026 | $248,999 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01EY038806 | Pax2 functions in postnatal retinal and optic nerve astrocytes | 000 | 1 | NIH | 6/24/2026 | $437,262 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01GM166753 | Spatially coordinated signaling directed by sensory organelles in innate immunity | 000 | 1 | NIH | 8/3/2026 | $521,604 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | K01AI201805 | Surveillance and Risk Prioritization of Bat-Borne Paramyxoviruses | 000 | 1 | NIH | 8/14/2026 | $205,956 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | F31NS149760 | Slow-Wave Sleep Enhancement to Treat Epilepsy | 000 | 1 | NIH | 6/19/2026 | $43,749 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R35GM161342 | ENGINEERING CELL-CELL ADHESION | 000 | 1 | NIH | 8/14/2026 | $672,980 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01HL187823 | Cardiac Regenerative Therapy Using Gene-Edited Stem Cells to Improve Transplantation Outcomes | 000 | 1 | NIH | 8/3/2026 | $590,503 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | F31NS147796 | Nuclear-cytoskeletal coupling through the giant KASH protein ANC-1 maintains neuronal mechanical integrity during aging | 000 | 1 | NIH | 8/14/2026 | $43,471 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R35GM164148 | Chemoenzymatic strategies for synthesizing glycans and glycoconjugates | 000 | 1 | NIH | 6/10/2026 | $675,667 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01GM166704 | Morphological reprogramming of the endoplasmic reticulum by cellular mucins | 000 | 1 | NIH | 7/27/2026 | $1,624,736 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01CA240751 | The Impact of Obesity on Radiotherapy Anti-Tumor Effects | 000 | 5 | NIH | 2/26/2026 | $539,696 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01DA056365 | High-throughput Identification of Non-hallucinogenic Psychoplastogens for Treating Addiction | 000 | 5 | NIH | 2/13/2026 | $541,161 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R00AG071837 | Regional tau deposition and digital assessment of cognition in preclinical AD and MCI | 002 | 4 | NIH | 8/12/2026 | $248,999 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R00AG071837 | Regional tau deposition and digital assessment of cognition in preclinical AD and MCI | 001 | 3 | NIH | 7/14/2026 | $112,700 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R00AG071837 | Regional tau deposition and digital assessment of cognition in preclinical AD and MCI | 001 | 3 | NIH | 7/14/2026 | -$112,700 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R00AG071837 | Regional tau deposition and digital assessment of cognition in preclinical AD and MCI | 000 | 3 | NIH | 1/21/2026 | $112,700 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01NS135005 | The electrical basis of proprioceptive signaling | 000 | 3 | NIH | 6/8/2026 | $476,507 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01EY026556 | Theranostics of Photoreceptor-RPE-Choroid Neurovascular Unit in Eye Diseases: | 000 | 9 | NIH | 2/11/2026 | $601,883 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R25GM160671 | A Mentoring and Skills Development Training Program in One Health | 000 | 2 | NIH | 4/22/2026 | $536,069 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R50CA276013 | NCI R50 Clinician Scientist Award | 000 | 4 | NIH | 3/19/2026 | $87,347 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01NS143205 | Role of post-transcriptional regulation on cortical cell fate specification | 000 | 2 | NIH | 6/25/2026 | $464,114 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01NS144894 | Investigations of Spatial Recognition Memory to Improve Cognitive Outcomes in Epilepsy Surgery | 001 | 2 | NIH | 6/19/2026 | $612,244 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01ES037331 | Pollutant-adsorbed nanoplastics (PANs): the influence of physicochemical properties on biodistribution and brain toxicity following inhalation | 000 | 1 | NIH | 4/14/2026 | $765,348 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R03AI196215 | Dengue virus NS4A protein dynamics drive membrane deformation | 000 | 1 | NIH | 7/9/2026 | $80,500 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01CA308808 | Dissecting the role of CPT1C in advanced prostate cancer | 000 | 1 | NIH | 3/20/2026 | $551,328 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | U19FD008633 | Enhance the Capacity and Capability to Test Animal and Human Foods in the Area of Chemical Testing through the Development of Special Projects and Food and Feed Monitoring Activities | 002 | 2 | FDA | 8/6/2026 | $415,000 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01DK140492 | A Novel Nanodrug for Metabolic Disease Treatment | 000 | 1 | NIH | 8/12/2026 | $803,565 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01CA301398 | Modeling extensive cellular variability in glycolytic rates using multiplexed live-cell data | 000 | 1 | NIH | 3/24/2026 | $648,177 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R03EB040241 | Systematic investigation of artifacts in deep learning-based PET image enhancement | 000 | 1 | NIH | 8/6/2026 | $80,500 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R35GM161914 | Decoding the Mechanisms and Regulatory Networks of Plant U-Box/RING Ubiquitin Ligase Complexes under biotic stress | 000 | 1 | NIH | 3/24/2026 | $390,881 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01EB037561 | Maximizing the Performance of Whole-Body PET Scanner | 000 | 1 | NIH | 8/18/2026 | $615,615 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R25NS141153 | UC Davis NEURO Program | 000 | 1 | NIH | 5/18/2026 | $126,845 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R21HD118459 | The cellular biology of lactation | 000 | 1 | NIH | 8/19/2026 | $442,187 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R03HD123301 | Unlocking Pediatric Genomic Variation: A Proposal to Index and Genotype the Kids First Cohort with The Great Genotyper | 000 | 1 | NIH | 8/10/2026 | $322,000 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01NS131379 | Alpha-Synuclein aberrantly modifies the nanoscale distribution and function of ion channels to promote neuronal cytotoxicity | 000 | 2 | NIH | 3/31/2026 | $539,408 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01HL187988 | Deciphering Tobacco Smoke-Driven Fibroblast Reprogramming in Pulmonary Fibrosis | 000 | 1 | NIH | 8/19/2026 | $770,045 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01NS151264 | JAK/STAT signaling as a therapeutic target to mitigate long-term effects of acute organophosphate intoxication | 000 | 1 | NIH | 8/20/2026 | $468,559 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R21MH141572 | Mechanisms of Satellite Oligodendroglia-Neuron Interaction in Brain Maturation | 000 | 1 | NIH | 6/22/2026 | $437,870 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R03DE035523 | Cyclooxygenase signaling in neural crest migration and craniofacial development | 000 | 1 | NIH | 7/2/2026 | $301,086 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | UM1TR005995 | UC Davis Clinical and Translational Science Center | 000 | 1 | NIH | 5/12/2026 | $5,755,059 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01NS146486 | Functional biology of alternative promoters in the cerebral cortex | 000 | 1 | NIH | 8/20/2026 | $622,252 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01EB039019 | Whole-Body PET Parametric Imaging for Pediatric Patients | 000 | 1 | NIH | 5/12/2026 | $2,238,460 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | R01AG094076 | Subjective cognitive decline as a risk for Alzheimer's disease and vascular cognitive impairment across diverse groups | 000 | 1 | NIH | 2/19/2026 | $690,934 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | F31DC023776 | An articulatory brain-computer interface approach for restoring expressive communication to people with paralysis | 001 | 1 | NIH | 4/9/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | F31DC023776 | An articulatory brain-computer interface approach for restoring expressive communication to people with paralysis | 000 | 1 | NIH | 4/9/2026 | $43,752 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | F32GM159401 | Elucidation of Gd(III)-Ligand and Gd(III)-Protein Complexes for Development of Gd(III) Contrast Agents Using High-Frequency EPR Spectroscopy | 002 | 1 | NIH | 3/26/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, DAVIS | 1850 RESEARCH PARK DR STE 300 | DAVIS | CA | 95618-6153 | YOLO | USA | F32GM159401 | Elucidation of Gd(III)-Ligand and Gd(III)-Protein Complexes for Development of Gd(III) Contrast Agents Using High-Frequency EPR Spectroscopy | 001 | 1 | NIH | 3/26/2026 | $1,308 |
|
